| firstname.lastname@example.org |
Women - Want to Drop 10-Ibs and Keep it Off For Good Easily?This Tip Is Not For Men
New research shows exactly WHY it is so much harder for women than it is for men to lose and keep off weight. This exciting tips really works.
You can expect to drop 3 dress sizes in only ONE week.
This unusual tip strategically allows you to eat what you'd like while losing dress sizes in the meanwhile.
You've never seen anything like this before.
Go Here to Find Out Exactly What This Trick Is:
| Notification that your factory warranty might be expiring or has currently expired! Confirm your extended protection Today|
This email is an advert isement to extend your coverage. Remove me from list 9 Gibson Dr Hazlet NJ 07730-2620
If you would no longer like to receive these from us, click here
A recent fossil find is more evidence that the well-known �Lucy� species was not alone in the region now known as Ethiopia, a new study suggests. A lower jaw, along with jaw fragments and teeth, dated at between 3.3 million to 3.5 million years old, were found in the Afar region of northern Ethiopia four years ago. The discovery shows that a second human ancestor lived in about the same area and time frame a Lucy�s species, researchers said. However, not everyone agrees with that notion. The journal Nature released a paper Wednesday announcing the new find and assigned it to a species they dubbed Australopithecus deyiremeda. In the Afar language the second name means �close relative,� referring to its apparent relationship to later members of the evolutionary tree. Yohannes Haile-Selassie of the Cleveland Museum of Natural History, who led the discovery team, says nobody knows just how it�s related to our own branch of the family tree. Previously, fossilized foot bones found in 2009 near the new discovery site had indicated the presence of a second species. But those bones were not assigned to any species, and it is still unclear whether they belong to the newly identified species, Haile-Selassie said. If they don't, that would indicate yet another species from the same time and region as Lucy's species, Australopithecus afarensis. Bernard Wood of George Washington University said the discovery provides �compelling evidence� that a second creature lived in the vicinity of Lucy�s species at the same time. Wood wonders how they shared the landscape. "These fossils certainly create an agenda for a lot of interesting research that's going to be done in the next decade," Wood said. As evidence that the new fossils represent a previously unknown species, the researchers cite specific anatomical differences with known fossils. But Tim White, a University of California, Berkeley, expert in human evolution, was unimpressed.
Patients who used cells from this STD to treat their melanoma were 8 times more likely to survive than a control group A genetically modified strain of herpes can kill cancer cells and stop tumors from growing, according to new research. The strain, called T-Vec, was used to treat patients with melanoma as part of one of the final phases of testing of a new drug. The research, published in the Journal of Clinical Oncology, is the latest to show how viruses may be used clinically to kill cancer cells. Unlike chemotherapy, which casts a wide net and kills any proliferating cells, viruses often narrowly target cancer cells, which could make them more effective in fighting the disease. The method also appeals to researchers because it activates the immune system to fight cancer.
|Researchers looked at more than 400 patients with aggressive malignant melanoma, the deadliest type of skin cancer. More than 16% of patients given the T-Vec treatment showed a lasting response for six months, compared with 2% of members of the control group given normal treatment. �We may normally think of viruses as the enemies of mankind, but it�s their very ability to specifically infect and kill human cells that can make them such promising cancer treatments,� said professor Paul Workman, chief executive of the Institute of Cancer Research, in a statement. The drug, produced by Amgen, now awaits approval from the U.S. Food and Drug Administration before it will be offered to patients.|